Cancer Health Treatment Update The World's Biggest Cancer Conference Goes Virtual See our reports from the American Society of Clinical Oncology virtual scientific program. Early Palliative Care Reduces Anxiety and Depression in People With Leukemia Starting palliative interventions at the onset of hospitalization for chemotherapy greatly improves quality of life. Overcoming Challenges for People with Head and Neck Cancers National Comprehensive Cancer Network guidelines offer expert advice on treatment and prevention. Integrating Geriatric Care Improves Quality of Life for Seniors With Cancer Other benefits include better cancer care planning for people over 70. For all of Cancer Health's coverage of the novel coronavirus and COVID-19, click here. UPDATED: Remdesivir Shows Promise for COVID-19, but Not a Game Changer Results from randomized clinical trials of the antiviral drug continue to show mixed results. Survey: Cancer Patients Increasingly Face COVID-19 Health Impact Second survey finds more delays in care, financial strain and negative mental health effects. Cancer Health Spring 2020 Check out our new print edition! Advertisement Newsfeed Early Palliative Care Reduces Anxiety and Depression in Acute Myeloid Leukemia Treatment How States Are Addressing COVID-19 Racial Disparities Do Chemicals in Sunscreen Cause Cancer? Survey: Cancer Patients Increasingly Face COVID-19 Health Impact Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment Newsfeed Early Palliative Care Reduces Anxiety and Depression in Acute Myeloid Leukemia Treatment How States Are Addressing COVID-19 Racial Disparities Do Chemicals in Sunscreen Cause Cancer? Survey: Cancer Patients Increasingly Face COVID-19 Health Impact Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: